- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Darolutamide (BAY1841788)
Total 72 results
-
BayerActive, not recruitingProstate CancerUnited States, Canada, Japan, Spain, Germany, Belgium, Argentina, Austria, Brazil, Greece, Italy, Russian Federation, Taiwan, China, Denmark, France, Colombia
-
BayerTerminatedProstatic Cancer, Castration-ResistantUnited States
-
BayerCompletedCerebrovascular CirculationUnited Kingdom
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerCanada
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerRecruitingCancerKorea, Republic of, Spain, United States, China, Australia, Austria, Belgium, Brazil, Colombia, Czechia, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Japan, Latvia, Lithuania, Netherlands, Peru, Poland, Portugal, Romania, Russian... and more
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, United States, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Australia, Canada, Hungary, Italy, Finland, United Kingdom, Brazil, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
BayerRecruitingNon-metastatic Castration-resistant Prostate CancerIndia
-
BayerRecruiting
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
BayerActive, not recruiting
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...First Affiliated Hospital of Zhejiang University; The First Affiliated Hospital...Recruiting
-
BayerOrion Corporation, Orion PharmaCompletedHepatic Insufficiency | Renal Insufficiency | PharmacokineticsGermany
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Intermitent Anti-androgen TherapyChina
-
Association Pour La Recherche des Thérapeutiques...BayerRecruiting
-
Peking University First HospitalThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaboratorsRecruiting
-
AstraZenecaRecruitingProstate CancerUnited States, Spain, United Kingdom, Netherlands, Canada, Australia
-
GenesisCare USABayerWithdrawn
-
D'Or Institute for Research and EducationBayer; RPH Central PharmaRecruiting
-
Institut Claudius RegaudBayerRecruiting
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
MANA RBMBayer; Tulane University; Barbara Ann Karmanos Cancer Institute; Carolina Urologic...TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
University Hospital, GhentRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | OligometastasisBelgium
-
Alliance Foundation Trials, LLC.BayerRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Castrate Resistant Prostate CancerUnited States
-
University Health Network, TorontoBayer; Prostate Cancer CanadaNot yet recruiting
-
Translational Research in OncologyBayerCompletedBreast Cancer FemaleGermany, Canada, United States
-
Eli Lilly and CompanyBayerActive, not recruitingProstatic NeoplasmsSpain, Germany, United States
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
National Cancer Center Hospital EastBayer Yakuhin, Ltd.Active, not recruitingSalivary Gland CancerJapan
-
Institut BergoniéBayerRecruiting
-
BayerOrion Corporation, Orion PharmaCompleted
-
UNICANCERCompletedBreast Cancer Female | Triple Negative and Androgen Receptor PositiveFrance
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
St Vincent's Hospital, SydneyRecruitingMetastatic Prostate CancerAustralia
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Erasmus Medical CenterRecruitingMetastatic Castration-resistant Prostate CancerNetherlands
-
Eli Lilly and CompanyCompletedHealthy VolunteersUnited States
-
BayerRecruiting
-
UNC Lineberger Comprehensive Cancer CenterRecruiting
-
Dana-Farber Cancer InstituteBayer; Decipher BiosciencesRecruiting
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
BayerCompletedHealthy Volunteers | Pharmacokinetics | Drug InteractionGermany